Professor Mike Themis is a Lecturer of Gene Therapy and Genotoxicity in the Department of Life Sciences at Brunel University London and an Honorary Lecturer at Imperial College London. His research at Brunel concerns gene mapping and cloning, gene therapy, basic bioinformatics, cancer and intellectual property law.
Mike is also a Founding Director of TestaVec Ltd, a spin-out of Brunel University to provide a comprehensive service that tests GT safety and efficacy intended for academic and pharmaceutical use in the clinic.
Please see his Brunel profile page for more information about Mike’s work and career to date:
Professor Michael Themis | Introduction | Brunel University London
Mike is visiting the CRI Section on 5th March to give a fascinating seminar on the “Development of an unbiased human iPSc model to determine gene therapy vector safety.”
Please join us in-person in the Wolfson Education Centre Seminar Room 5 or via Teams.